Difference between revisions of "ELOC-mutated renal cell carcinoma"
Jump to navigation
Jump to search
(→Molecular lacking: tweak) |
|||
Line 89: | Line 89: | ||
NEGATIVE: CK34betaE12, CK20. | NEGATIVE: CK34betaE12, CK20. | ||
The staining and morphology raises the possibility of a | The staining and morphology raises the possibility of a TCEB1 mutation, described | ||
in a subset of clear cell renal cell carcinoma.[1] | in a subset of clear cell renal cell carcinoma.[1] | ||
Revision as of 19:50, 28 February 2017
ELOC-mutated renal cell carcinoma | |
---|---|
Diagnosis in short | |
RCC with clear cells and fibromuscular band - morphology compatible with TCEB1 mutation. H&E stain. (WC) | |
| |
LM | clear cells with abundant cytoplasm and basal nuclei (may have luminal nuclei), usually ISUP nucleolar grade 2, fibromuscular bands |
LM DDx | clear cell renal cell carcinoma, clear cell tubulopapillary renal cell carcinoma |
IHC | CK7 +ve, CD10 +ve, CK34betaE12 -ve |
Molecular | TCEB1 mutation |
Site | kidney - see kidney tumours |
| |
Syndromes | possibly tuberous sclerosis - see tuberous sclerosis-associated renal cell carcinoma |
| |
Prevalence | very rare - evolving entity |
Prognosis | good - based on limited data |
TCEB1-mutated renal cell carcinoma, also renal cell carcinoma with TCEB1 mutation, is an evolving entity that is morphologically similar to clear cell renal cell carcinoma and clear cell tubulopapillary renal cell carcinoma.[1]
It should not be confused with TFEB renal cell carcinoma, also known as renal tumour with t(6;11) translocation.
This entity is not recognized by the WHO classification of renal neoplasia. It probably represents the previously described renal angiomyoadenomatous tumour,[1][2] that was lumped with clear cell papillary renal cell carcinoma in the Vancouver modification of the WHO classification.
General
- Evolving entity.
- TCEB1 (transcription elongation factor B, polypeptide 1) is part of a complex that binds with the product of the VHL gene;[3] thus, it acts as a tumour suppressor.
- Good prognosis - based on limited data.[1]
Gross
- Cystic changes.
Microscopic
Features:
- Clear cells with abundant cytoplasm and basal nuclei.
- Luminal nuclei (like in clear cell tubulopapillary RCC) may be seen.
- Usually ISUP nucleolar grade 2.
- Fibromuscular bands - key feature.
DDx:
- Clear cell renal cell carcinoma.
- Clear cell tubulopapillary renal cell carcinoma - have luminal nuclei.
- Tuberous sclerosis-associated renal cell carcinoma.
Images
Morphology compatible
IHC
Features:[1]
- CK7 +ve.
- CD10 +ve.
- Typically negative in clear cell tubulopapillary renal cell carcinoma.
- CK34betaE12 -ve.
- Usually positive in clear cell tubulopapillary renal cell carcinoma.
Sign out
Molecular lacking
Right Kidney, Radical Nephrectomy: - CLEAR CELL RENAL CELL CARCINOMA with cysts and leiomyomatous stroma, see comment. -- Margin clear. -- Please see synoptic report for details. Comment: The tumour stains as follows: POSITIVE: CD10 (moderate), EMA (patchy), CAM5.2, CK7 (focal), PAX8 (diffuse). NEGATIVE: CK34betaE12, CK20. The staining and morphology raises the possibility of a TCEB1 mutation, described in a subset of clear cell renal cell carcinoma.[1] 1. Mod Pathol 28 (6): 845-53. doi:10.1038/modpathol.2015.6. PMID 25676555.
See also
- Vancouver classification.
- Renal angiomyoadenomatous tumour (renal cell carcinoma with angioleiomyoma-like stroma).
References
- ↑ 1.0 1.1 1.2 1.3 Hakimi, AA.; Tickoo, SK.; Jacobsen, A.; Sarungbam, J.; Sfakianos, JP.; Sato, Y.; Morikawa, T.; Kume, H. et al. (Jun 2015). "TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.". Mod Pathol 28 (6): 845-53. doi:10.1038/modpathol.2015.6. PMID 25676555.
- ↑ Michal, M.; Hes, O.; Kuroda, N.; Kazakov, DV.; Hora, M. (Jun 2009). "Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma.". Virchows Arch 454 (6): 719. doi:10.1007/s00428-009-0788-9. PMID 19471960.
- ↑ URL: http://www.omim.org/entry/600788. Accessed on: 12 June 2015.